Key Findings:  The endocannabinoid system through CB1 receptors promotes cisplatin-induced tissue injury by amplifying MAPK activation, cell death and interrelated inflammation and oxidative/nitrosative stress. These results also suggest that inhibition of CB1 receptors (e.g., AM281 or SR141716) with may exert beneficial effects in renal (and most likely other) diseases associated with enhanced inflammation, oxidative/nitrosative stress and cell death.
Type of Study:  Animal Study
Study Result:  Positive
Study Location(s):  China, United States
Year of Pub:  2010
Cannabinoids Studied:  AM-x Synthetic Cannabinoids, SR-x Synthetic Cannabinoids, Anandamide (AEA), 2-Arachidonoyl Glycerol (2-AG)
Phytocannabinoid Source:  Not Applicable
Ligands Studied:  Anti-inflammatory cytokines, Pro-inflammatory cytokines